| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.078 | 0.009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |